MBX Biosciences gets FDA green light to move second drug into human testing

Please subscribe to IBJ to decode this article.

gcuih0r , sir.omunp, yrg xe droeoeot1fc u5tp hu nvamctu tn aetlrocmsreefo oiaisrnp siacnmedniee Btoatdnt d lplamtv Xmles nase ternfna gd r l Cahiceusles ngiiMvrgeasr reeteBsniiant oeia$hea-eipdn ela

irt a ocyoc .maes cSytc pufaniUhna tp mesropa d ren.eMoAertifsnT anuna - t a tynao vrgi irdyyialraX.r edaio B obdst rinti,h eegagei eh irsdg,gmhls atodatrtea i oiodor gtatDM aehr usFmrodogci ecpbsolsu

vsssbde eeeses ss.sw vilgeeii,iedsu c ez syrcedndpweae xait npnlonore ax tmmneti eyoicii .cu ohasucrteeaoA,y, tg n iseewsn iaissroleieiEedmnoyrvr iia l tlkucehe aes s.np fmgtfospr emu e ivu lo nlad,er orln hecf szyTi,rvaeapekuifssmtsowbsl eo lnormcle,alboosoldor trnaoesplopssndgit rssz od ueselruos dtm s cay

nrmriolstadhcasirrssln rTtraar lis f qfapue tplhtl-msttatedc.2irnfnlo a ytr dininue 4eelstdm 0aih on on t ei s o oal t rin nisie hoathac2ltse reypg eapyyc uehea

demtlkt somEurvmi 1eyuftedcedcn , Dflehtsy awertre tihhiatrmrel u cpueiisaoaca fthoehtoacmee” iAsalnsa e rii oecbX6dfe Kt H a,olnrphlneodpa mn.wHd ter F rdadr -r4iteo me yolssi a“c O1ettottamcego- bdMxpla ti-o llrintfn ssaheg,oaeapil .nsenysaC nacnu-eaBelngcndf

taa iyeurdea clen2iH10lrMuhnire sh9ndnniimesawlrfd ieeItM,ea rd ryrnst hi rta i.Xainvui soesDccai erkwapnrreb rhdo aahRy eUneprngs drn mcyBt

i do-d ueu e2wp-tac /h-g,tryigvdshnceMc/sniswtttaBiBtidvcaamiwuaeslyk>rauero.Ih

recmwaiik ulhcrgDnaBvoh dd ebbe Mratrim rasc aap Nubg aSr wboMo2. agtcrs ieteaoo snulaltt.odykshis tRhaNea-

opiacr ioho isst n BansanGcu nti,cdsgnchPhasieit ildyselh1no e eiIv n. m e m’ osP un,rc cXdnct auPhnrroan se asfLe6saMt ait indisicnegM gmtlteeeti onegdatrcsiwX eeB sgdow,gtnr4eiiesn itaai o1seop .raih ap-hmopnlsitcatot searde1rt E e-niyluds oiertlntmt imprt gnoitoeirb k fcit np onfg

f,oetl dnitfa masn ntpn2a giih dnltsnbien, lmirass 9yi ssi ,s yinr’ddev,alendtciahcoetk atr-tlime amcdheyarilian uh T uriae lgooacfBrtpcXeueo redddcbdrp hdgsce dolarpsupo s ceprr naei st nrofn yumeditnooeppn emasnsomr ns aa eootnwst mlosi im e,nhnae in, aaptt aytashicr rums rctoasoe lfnmrudofenystu inm0iclrsd en.pyp le meroyaloaa h1diss haydMtdsnneuanscegflno

nuta ns.rsvpeee or-h olsaae ir serl1imltinbedi dsbts uthaegDfurmrpv EaId otdtanhaL etgcn stneiidc dtnm aaops e 0ltnfrnepoa onohen drn0i 0rpimbay e ip caeusodse lmh1epafcssicrpns.hl5atginhs ie ditioin rreMt 2o3ch0 la asie s opy cpie ia iao fcn ap ree.oec vl 0HCh

oe b, evAer Bsns.empauoiintd d0tsar nlitxduAl,0fsgHioroonfu mfCn rrcceheelaatsalsretbeA5uyndbhte sei tlrlsntopsh rricymo.as is ilpuw r snmioal one rd $ism

sanonnaeetsr,jka agMn, ngWP ab ttNedl mFdr cnMtoicpionMne,r C ugrnes dwVLeeeorialr ieOetMMoea n tef c res clediages SARarnt. Nsntslnfeb uwzEBaieimX,aiAacra el

psn;b&

s& ;bpn

/